{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:26:18Z","timestamp":1792110378049,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,15]]},"DOI":"10.7759\/cureus.101581","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:58:21Z","timestamp":1768467501000},"source":"Crossref","is-referenced-by-count":2,"title":["A Systematic Literature Review of the Epidemiological, Diagnostic Workup, Humanistic, and Economic Burden of Alzheimer\u2019s Disease in Spain"],"prefix":"10.7759","author":[{"given":"Miren","family":"Altuna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eloy","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Trueba-Saiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Lizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"D\u00edaz-Cerezo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Grupo estatal de demencias-ministerio de sanidad. Plan integral de alzheimer y otras demencias (2019-2023). Ministerio de sanidad","author":"Ministerio de Sanidad","year":"2019","unstructured":"Ministerio de Sanidad. Comprehensive Plan for Alzheimer\u2019s Disease and Other Dementias (2019-2023) (Book in Spanish). Ministerio de Sanidad, Madrid, Spain; 2019. https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/docs\/Plan_Integral_Alhzeimer_Octubre_2019.pdf."},{"key":"ref2","article-title":"Sociedad espa\u00f1ola de neurolog\u00eda. Impacto sociosanitario de las enfermedades neurol\u00f3gicas en espa\u00f1a","author":"Sociedad Espa\u00f1ola de Neurolog\u00eda","year":"2024","unstructured":"Sociedad Espa\u00f1ola de Neurolog\u00eda.  Socioeconomic and Healthcare Impact of Neurological Diseases in Spain (Book in Spanish). Sociedad Espa\u00f1ola de Neurolog\u00eda, Barcelona, Spain; 2024. https:\/\/www.sen.es\/pdf\/2024\/Informe_sociosanitario_2024.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115522","article-title":"Alzheimer's disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs","volume":"211","author":"Monteiro AR","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R. Alzheimer's disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol. 2023, 211:115522. 10.1016\/j.bcp.2023.115522","journal-title":"Biochem Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12060110","article-title":"Early- and late-onset Alzheimer\u2019s disease: two sides of the same coin?","volume":"12","author":"Valdez-Gaxiola CA","year":"2024","unstructured":"Valdez-Gaxiola CA, Rosales-Leycegui F, Gaxiola-Rubio A, Moreno-Ortiz JM, Figuera LE. Early- and late-onset Alzheimer\u2019s disease: two sides of the same coin?. Diseases. 2024, 12:110. 10.3390\/diseases12060110","journal-title":"Diseases"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer's disease: treatment strategies and their limitations","volume":"23","author":"Passeri E","year":"2022","unstructured":"Passeri E, Elkhoury K, Morsink M, et al.. Alzheimer's disease: treatment strategies and their limitations. Int J Mol Sci. 2022, 23:13954. 10.3390\/ijms232213954","journal-title":"Int J Mol Sci"},{"key":"ref6","unstructured":"Resident population by date, sex, age group and nationality. (2024). Accessed. May 23, 2024: https:\/\/www.ine.es\/jaxiT3\/Datos.htm?t=56936#_tabs-tabla."},{"key":"ref7","unstructured":"Thirty-five percent of Alzheimer\u2019s cases can be attributed to nine modifiable risk factors. (2024). Accessed. May 23, 2024: https:\/\/www.sen.es\/saladeprensa\/pdf\/Link280.pdf."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2021.23","article-title":"Diagnosis of early Alzheimer's disease: clinical practice in","volume":"8","author":"Porsteinsson AP","year":"2021","unstructured":"Porsteinsson AP, Isaacson RS, Knox S, Sabbagh MN, Rubino I. Diagnosis of early Alzheimer's disease: clinical practice in. J Prev Alzheimers Dis. 2021, 8:371-86. 10.14283\/jpad.2021.23","journal-title":"J Prev Alzheimers Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201597","article-title":"Diagnostic performance and clinical applicability of blood-based biomarkers in a prospective memory clinic cohort","volume":"100","author":"Sarto J","year":"2023","unstructured":"Sarto J, Ruiz-Garc\u00eda R, Guill\u00e9n N, et al.. Diagnostic performance and clinical applicability of blood-based biomarkers in a prospective memory clinic cohort. Neurology. 2023, 100:e860-73. 10.1212\/WNL.0000000000201597","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01513-9","article-title":"Diagnostic performance of plasma pTau(217), pTau(181), A\u03b2(1-42) and A\u03b2(1-40) in the LUMIPULSE automated platform for the detection of Alzheimer disease","volume":"16","author":"Arranz J","year":"2024","unstructured":"Arranz J, Zhu N, Rubio-Guerra S, et al.. Diagnostic performance of plasma pTau(217), pTau(181), A\u03b2(1-42) and A\u03b2(1-40) in the LUMIPULSE automated platform for the detection of Alzheimer disease. Alzheimers Res Ther. 2024, 16:139. 10.1186\/s13195-024-01513-9","journal-title":"Alzheimers Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/alz.092576","article-title":"Systematic review of brief cognitive screening tools for identifying dementia and mild cognitive impairment in illiterate and low\u2010educated populations","volume":"20","author":"Zegarra\u2010Valdivia JA","year":"2025","unstructured":"Zegarra\u2010Valdivia JA, Chino\u2010Vilca BN, Tituana KA, et al.. Systematic review of brief cognitive screening tools for identifying dementia and mild cognitive impairment in illiterate and low\u2010educated populations. Alzheimers Dement. 2025, 20:e092576. 10.1002\/alz.092576","journal-title":"Alzheimers Dement"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.32481\/djph.2021.09.009","article-title":"Diagnosis and treatment of Alzheimer's disease: an update","volume":"7","author":"Bomasang-Layno E","year":"2021","unstructured":"Bomasang-Layno E, Bronsther R. Diagnosis and treatment of Alzheimer's disease: an update. Dela J Public Health. 2021, 7:74-85. 10.32481\/djph.2021.09.009","journal-title":"Dela J Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2014.06.004","article-title":"Innovative diagnostic tools for early detection of Alzheimer's disease","volume":"11","author":"Laske C","year":"2015","unstructured":"Laske C, Sohrabi HR, Frost SM, et al.. Innovative diagnostic tools for early detection of Alzheimer's disease. Alzheimers Dement. 2015, 11:561-78. 10.1016\/j.jalz.2014.06.004","journal-title":"Alzheimers Dement"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack CR Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al.. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018, 14:535-62. 10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220587","article-title":"Alzheimer\u2019s disease diagnosis based on the amyloid, tau, and neurodegeneration scheme (ATN) in a real-life multicenter cohort of general neurological centers","volume":"90","author":"Baldeiras I","year":"2022","unstructured":"Baldeiras I, Silva-Sp\u00ednola A, Lima M, et al.. Alzheimer\u2019s disease diagnosis based on the amyloid, tau, and neurodegeneration scheme (ATN) in a real-life multicenter cohort of general neurological centers. J Alzheimers Dis. 2022, 90:419-32. 10.3233\/JAD-220587","journal-title":"J Alzheimers Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.90.15_supplement.P4.182","article-title":"Diagnostic accuracy of biomarker combinations in the A\/T\/N classification for Alzheimer\u2019s disease (P4.182)","volume":"90","author":"Mendez P","year":"2018","unstructured":"Mendez P, Calandri I, Demey I, et al.. Diagnostic accuracy of biomarker combinations in the A\/T\/N classification for Alzheimer\u2019s disease (P4.182). Neurol J. 2018, 90:182. 10.1212\/WNL.90.15_supplement.P4.182","journal-title":"Neurol J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12407","article-title":"Erratum: Alzheimer's disease drug development pipeline: 2023","volume":"9","year":"2023","unstructured":"Erratum. Alzheimer's disease drug development pipeline: 2023. Alzheimers Dement (N Y). 2023, 9:e12407. 10.1002\/trc2.12407","journal-title":"Alzheimers Dement (N Y)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-022-01212-z","article-title":"The costs of dementia in Europe: an updated review and meta-analysis","volume":"41","author":"J\u00f6nsson L","year":"2023","unstructured":"J\u00f6nsson L, Tate A, Frisell O, Wimo A. The costs of dementia in Europe: an updated review and meta-analysis. Pharmacoeconomics. 2023, 41:59-75. 10.1007\/s40273-022-01212-z","journal-title":"Pharmacoeconomics"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.regg.2018.10.008","article-title":"Alzheimer's disease and the quality of life of the informal caregiver (Article in Spanish)","volume":"54","author":"Casal Rodr\u00edguez B","year":"2019","unstructured":"Casal Rodr\u00edguez B, Rivera Casti\u00f1eira B, Currais Nunes L. Alzheimer's disease and the quality of life of the informal caregiver (Article in Spanish). Rev Esp Geriatr Gerontol. 2019, 54:81-7. 10.1016\/j.regg.2018.10.008","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/PRBM.S274758","article-title":"Understanding resilience factors among caregivers of people with Alzheimer's disease in Spain","volume":"13","author":"Dur\u00e1n-G\u00f3mez N","year":"2020","unstructured":"Dur\u00e1n-G\u00f3mez N, Guerrero-Mart\u00edn J, P\u00e9rez-Civantos D, L\u00f3pez Jurado CF, Palomo-L\u00f3pez P, C\u00e1ceres MC. Understanding resilience factors among caregivers of people with Alzheimer's disease in Spain. Psychol Res Behav Manag. 2020, 13:1011-25. 10.2147\/PRBM.S274758","journal-title":"Psychol Res Behav Manag"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-215648","article-title":"Sex, neuropsychiatric profiles, and caregiver burden in Alzheimer's disease dementia: a latent class analysis","volume":"89","author":"Rosende-Roca M","year":"2022","unstructured":"Rosende-Roca M, Ca\u00f1abate P, Moreno M, et al.. Sex, neuropsychiatric profiles, and caregiver burden in Alzheimer's disease dementia: a latent class analysis. J Alzheimers Dis. 2022, 89:993-1002. 10.3233\/JAD-215648","journal-title":"J Alzheimers Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009, 339:b2535. 10.1136\/bmj.b2535","journal-title":"BMJ"},{"key":"ref23","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2012). Accessed. May 23, 2024: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200774","article-title":"Incidence of dementia and associated factors in the EPIC-Spain dementia cohort","volume":"78","author":"Andreu-Rein\u00f3n ME","year":"2020","unstructured":"Andreu-Rein\u00f3n ME, Huerta JM, Gavrila D, et al.. Incidence of dementia and associated factors in the EPIC-Spain dementia cohort. J Alzheimers Dis. 2020, 78:543-55. 10.3233\/JAD-200774","journal-title":"J Alzheimers Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11212852","article-title":"Falls and sleep disorders in Spanish Alzheimer's disease in nursing homes: an observational study","volume":"11","author":"C\u00e1mara-Calmaestra R","year":"2023","unstructured":"C\u00e1mara-Calmaestra R, Mart\u00ednez-Amat A, Aibar-Almaz\u00e1n A, et al.. Falls and sleep disorders in Spanish Alzheimer's disease in nursing homes: an observational study. Healthcare (Basel). 2023, 11:2852. 10.3390\/healthcare11212852","journal-title":"Healthcare (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8110457","article-title":"Depression as a risk factor for dementia and Alzheimer's disease","volume":"8","author":"Cant\u00f3n-Habas V","year":"2020","unstructured":"Cant\u00f3n-Habas V, Rich-Ruiz M, Romero-Salda\u00f1a M, Carrera-Gonz\u00e1lez MD. Depression as a risk factor for dementia and Alzheimer's disease. Biomedicines. 2020, 8:457. 10.3390\/biomedicines8110457","journal-title":"Biomedicines"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1080\/14737167.2020.1820328","article-title":"Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study","volume":"21","author":"Darb\u00e0 J","year":"2021","unstructured":"Darb\u00e0 J, Mars\u00e0 A. Hospital incidence, mortality and costs of Alzheimer's disease in Spain: a retrospective multicenter study. Expert Rev Pharmacoecon Outcomes Res. 2021, 21:1101-6. 10.1080\/14737167.2020.1820328","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref28","article-title":"Prevalence of drug prescription in Alzheimer's disease and use of combination therapy (Article in Spanish)","volume":"33","author":"Fern\u00e1ndez-Rubio B","year":"2023","unstructured":"Fern\u00e1ndez-Rubio B, Saborido-Cansino C. Prevalence of drug prescription in Alzheimer's disease and use of combination therapy (Article in Spanish). Rev OFIL\u00b7ILAPHAR. 2023, 33:79-82.","journal-title":"Rev OFIL\u00b7ILAPHAR"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220930","article-title":"NEURONORMA cognitive battery associations with cerebrospinal fluid amyloid-\u03b2 and tau levels in the continuum of Alzheimer's disease","volume":"92","author":"Garc\u00eda-Escobar G","year":"2023","unstructured":"Garc\u00eda-Escobar G, Puig-Pijoan A, Puente-Periz V, et al.. NEURONORMA cognitive battery associations with cerebrospinal fluid amyloid-\u03b2 and tau levels in the continuum of Alzheimer's disease. J Alzheimers Dis. 2023, 92:1303-21. 10.3233\/JAD-220930","journal-title":"J Alzheimers Dis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S282147","article-title":"Assessing knowledge and perceptions of Alzheimer's disease among employees of a pharmaceutical company in Spain: a comparison between caregivers and non-caregivers","volume":"14","author":"Garcia-Ribas G","year":"2020","unstructured":"Garcia-Ribas G, Garc\u00eda-Arcelay E, Montoya A, Maurino J. Assessing knowledge and perceptions of Alzheimer's disease among employees of a pharmaceutical company in Spain: a comparison between caregivers and non-caregivers. Patient Prefer Adherence. 2020, 14:2357-64. 10.2147\/PPA.S282147","journal-title":"Patient Prefer Adherence"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000416","article-title":"Sex moderates the relationship of stress and perceived social support with neuropsychological symptoms among community-dwelling persons with Alzheimer disease in Spain","volume":"35","author":"Gomez-Gallego M","year":"2021","unstructured":"Gomez-Gallego M, Gallego-Mellado M, G\u00f3mez-Gallego JC, G\u00f3mez-Garc\u00eda JG. Sex moderates the relationship of stress and perceived social support with neuropsychological symptoms among community-dwelling persons with Alzheimer disease in Spain. Alzheimer Dis Assoc Disord. 2021, 35:353-5. 10.1097\/WAD.0000000000000416","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s41669-023-00451-w","article-title":"Cost of patients with Alzheimer's disease in Spain according to disease severity","volume":"8","author":"G\u00f3mez Maldonado L","year":"2024","unstructured":"G\u00f3mez Maldonado L, de Mora-Figueroa R, L\u00f3pez-Angarita A, Maravilla-Herrera P, Merino M. Cost of patients with Alzheimer's disease in Spain according to disease severity. Pharmacoecon Open. 2024, 8:103-14. 10.1007\/s41669-023-00451-w","journal-title":"Pharmacoecon Open"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/hsc.13134","article-title":"Perceived health, caregiver overload and perceived social support in family caregivers of patients with Alzheimer's: gender differences","volume":"29","author":"Hern\u00e1ndez-Padilla JM","year":"2021","unstructured":"Hern\u00e1ndez-Padilla JM, Ruiz-Fern\u00e1ndez MD, Granero-Molina J, Ort\u00edz-Amo R, L\u00f3pez Rodr\u00edguez MM, Fern\u00e1ndez-Sola C. Perceived health, caregiver overload and perceived social support in family caregivers of patients with Alzheimer's: gender differences. Health Soc Care Community. 2021, 29:1001-9. 10.1111\/hsc.13134","journal-title":"Health Soc Care Community"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-190760","article-title":"Multi-national, cross-sectional survey of healthcare resource utilization in patients with all stages of cognitive impairment, analyzed by disease severity, country, and geographical region","volume":"75","author":"Khandker RK","year":"2020","unstructured":"Khandker RK, Ritchie CW, Black CM, Wood R, Jones E, Hu X, Ambegaonkar BM. Multi-national, cross-sectional survey of healthcare resource utilization in patients with all stages of cognitive impairment, analyzed by disease severity, country, and geographical region. J Alzheimers Dis. 2020, 75:1141-52. 10.3233\/JAD-190760","journal-title":"J Alzheimers Dis"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/08919887221130269","article-title":"Family carers of people with dementia in Japan, Spain, and the UK: a cross-cultural comparison of the relationships between experiential avoidance, cognitive fusion, and carer depression","volume":"36","author":"Kishita N","year":"2023","unstructured":"Kishita N, Morimoto H, M\u00e1rquez-Gonz\u00e1lez M, et al.. Family carers of people with dementia in Japan, Spain, and the UK: a cross-cultural comparison of the relationships between experiential avoidance, cognitive fusion, and carer depression. J Geriatr Psychiatry Neurol. 2023, 36:254-64. 10.1177\/08919887221130269","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref36","doi-asserted-by":"crossref","DOI":"10.6018\/eglobal.392231","article-title":"Women with a high level of education, victims of caregiving for people with Alzheimer\u2019s disease (Article in Spanish)","volume":"19","author":"Luque-Carrillo P","year":"2020","unstructured":"Luque-Carrillo P, Morales-Can\u00e9 I, Carmona-Torres JM, Manfredini R, Rodr\u00edguez-Borrego MA, L\u00f3pez-Soto P. Women with a high level of education, victims of caregiving for people with Alzheimer\u2019s disease (Article in Spanish). Enfermer\u00eda Global. 2020, 19:390-420.","journal-title":"Enfermer\u00eda Global"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200963","article-title":"Risk variants in three Alzheimer's disease genes show association with EEG endophenotypes","volume":"80","author":"Macedo A","year":"2021","unstructured":"Macedo A, G\u00f3mez C, Rebelo M\u00c2, et al.. Risk variants in three Alzheimer's disease genes show association with EEG endophenotypes. J Alzheimers Dis. 2021, 80:209-23. 10.3233\/JAD-200963","journal-title":"J Alzheimers Dis"},{"key":"ref38","article-title":"Resilience and burden in family caregivers of patients with dementias in Navarre (Article in Spanish)","volume":"33","author":"Mariezcurrena-Fern\u00e1ndez A","year":"2022","unstructured":"Mariezcurrena-Fern\u00e1ndez A, Lorea-Gonz\u00e1lez I, Remirez de Ganuza A, Ijalba-P\u00e9rez P, Barea-Ullate V, Jim\u00e9nez-Acosta A. Resilience and burden in family caregivers of patients with dementias in Navarre (Article in Spanish). Gerokomos. 2022, 33:88-94.","journal-title":"Gerokomos"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.regg.2020.09.008","article-title":"Prevalence of prescription of anticholinergic\/sedative burden drugs among older people with dementia living in nursing homes (Article in Spanish)","volume":"56","author":"Mart\u00ednez Arrechea S","year":"2021","unstructured":"Mart\u00ednez Arrechea S, Ferro Uriguen A, Beobide Telleria I, Gonz\u00e1lez Bueno J, Alaba Trueba J, Sevilla S\u00e1nchez D. Prevalence of prescription of anticholinergic\/sedative burden drugs among older people with dementia living in nursing homes (Article in Spanish). Rev Esp Geriatr Gerontol. 2021, 56:11-7. 10.1016\/j.regg.2020.09.008","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-020-00625-2","article-title":"Is it time to use real-world data from primary care in Alzheimer's disease?","volume":"12","author":"Ponjoan A","year":"2020","unstructured":"Ponjoan A, Garre-Olmo J, Blanch J, et al.. Is it time to use real-world data from primary care in Alzheimer's disease?. Alzheimers Res Ther. 2020, 12:60. 10.1186\/s13195-020-00625-2","journal-title":"Alzheimers Res Ther"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.33588\/rn.7508.2022180","article-title":"Effectiveness of a psychotherapeutic intervention group program in the improvement of caregiver well-being in Alzheimer's disease patients' family caregivers: the CuiDem study (Article in Spanish)","volume":"75","author":"Poudevida S","year":"2022","unstructured":"Poudevida S, de Sola S, Brugulat-Serrat A, et al.. Effectiveness of a psychotherapeutic intervention group program in the improvement of caregiver well-being in Alzheimer's disease patients' family caregivers: the CuiDem study (Article in Spanish). Rev Neurol. 2022, 75:203-11. 10.33588\/rn.7508.2022180","journal-title":"Rev Neurol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2022.05.002","article-title":"The CORCOBIA study: cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort","volume":"39","author":"Puig-Pijoan A","year":"2024","unstructured":"Puig-Pijoan A, Garc\u00eda-Escobar G, Fern\u00e1ndez-Lebrero A, et al.. The CORCOBIA study: cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort. Neurologia (Engl Ed). 2024, 39:756-65. 10.1016\/j.nrleng.2022.05.002","journal-title":"Neurologia (Engl Ed)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3233\/ADR230007","article-title":"Current diagnostic pathways for Alzheimer's disease: a cross-sectional real-world study across six countries","volume":"7","author":"Roth S","year":"2023","unstructured":"Roth S, Burnie N, Suridjan I, Yan JT, Carboni M. Current diagnostic pathways for Alzheimer's disease: a cross-sectional real-world study across six countries. J Alzheimers Dis Rep. 2023, 7:659-74. 10.3233\/ADR230007","journal-title":"J Alzheimers Dis Rep"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph16193762","article-title":"Predictor factors of perceived health in family caregivers of people diagnosed with mild or moderate Alzheimer's disease","volume":"16","author":"Ruiz-Fern\u00e1ndez MD","year":"2019","unstructured":"Ruiz-Fern\u00e1ndez MD, Hern\u00e1ndez-Padilla JM, Ortiz-Amo R, Fern\u00e1ndez-Sola C, Fern\u00e1ndez-Medina IM, Granero-Molina J. Predictor factors of perceived health in family caregivers of people diagnosed with mild or moderate Alzheimer's disease. Int J Environ Res Public Health. 2019, 16:3762. 10.3390\/ijerph16193762","journal-title":"Int J Environ Res Public Health"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17103398","article-title":"Prevalence of comorbidities in individuals diagnosed and undiagnosed with Alzheimer\u2019s disease in Le\u00f3n, Spain and a proposal for contingency procedures to follow in the case of emergencies involving people with Alzheimer\u2019s disease","volume":"17","author":"Tortajada-Soler M","year":"2020","unstructured":"Tortajada-Soler M, S\u00e1nchez-Valde\u00f3n L, Blanco-Nistal M, Ben\u00edtez-Andrades JA, Li\u00e9bana-Presa C, Bay\u00f3n-Darkistade E. Prevalence of comorbidities in individuals diagnosed and undiagnosed with Alzheimer\u2019s disease in Le\u00f3n, Spain and a proposal for contingency procedures to follow in the case of emergencies involving people with Alzheimer\u2019s disease. Int J Environ Res Public Health. 2020, 17:3398. 10.3390\/ijerph17103398","journal-title":"Int J Environ Res Public Health"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-200350","article-title":"Caregivers' sense of coherence: implications on direct and indirect costs of dementia care","volume":"78","author":"Turr\u00f3-Garriga O","year":"2020","unstructured":"Turr\u00f3-Garriga O, Vi\u00f1as-D\u00edez V, Conde-Sala JL, et al.. Caregivers' sense of coherence: implications on direct and indirect costs of dementia care. J Alzheimers Dis. 2020, 78:117-26. 10.3233\/JAD-200350","journal-title":"J Alzheimers Dis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2016.02.009","article-title":"Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis","volume":"32","author":"Niu H","year":"2017","unstructured":"Niu H, \u00c1lvarez-\u00c1lvarez I, Guill\u00e9n-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis. Neurolog\u00eda (English Edition). 2017, 32:523-32. 10.1016\/j.nrleng.2016.02.009","journal-title":"Neurolog\u00eda (English Edition)"},{"key":"ref48","article-title":"Junta de anadaluc\u00eda. Plan integral de alzheimer y otras demencias en andaluc\u00eda","author":"Regional Government of Andalusia","year":"2023","unstructured":"Regional Government of Andalusia. Comprehensive Plan for Alzheimer\u2019s Disease and Other Dementias in Andalusia (Book in Spanish). Regional Government of Andalusia, Seville, Spain; 2023. https:\/\/www.juntadeandalucia.es\/sites\/default\/files\/inline-files\/2023\/10\/PIAD_septiembre2023_final.pdf."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/alz.070829","article-title":"Catalan early onset dementia network 2021 report","volume":"19","author":"Guill\u00e9n N","year":"2023","unstructured":"Guill\u00e9n N, Balasa  M, Boada M, et al.. Catalan early onset dementia network 2021 report. Alzheimer's Dement. 2023, 19:e070829. 10.1002\/alz.070829","journal-title":"Alzheimer's Dement"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4841","article-title":"Diagnosis of cognitive decline and dementia in rural areas\u2009-\u2009a scoping review","volume":"33","author":"Barth J","year":"2018","unstructured":"Barth J, Nickel F, Kolominsky-Rabas PL. Diagnosis of cognitive decline and dementia in rural areas\u2009-\u2009a scoping review. Int J Geriatr Psychiatry. 2018, 33:459-74. 10.1002\/gps.4841","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1080\/07317115.2022.2054391","article-title":"Inequitable access to dementia diagnosis and care in low-resource settings - a global perspective","volume":"46","author":"Seeher K","year":"2023","unstructured":"Seeher K, Cataldi R, Dua T, Kestel D. Inequitable access to dementia diagnosis and care in low-resource settings - a global perspective. Clin Gerontol. 2023, 46:133-7. 10.1080\/07317115.2022.2054391","journal-title":"Clin Gerontol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1017\/S0714980819000564","article-title":"Dementia-related education and support service availability, accessibility, and use in rural areas: barriers and solutions","volume":"39","author":"Bayly M","year":"2020","unstructured":"Bayly M, Morgan D, Froehlich Chow A, Kosteniuk J, Elliot V. Dementia-related education and support service availability, accessibility, and use in rural areas: barriers and solutions. Can J Aging. 2020, 39:545-85. 10.1017\/S0714980819000564","journal-title":"Can J Aging"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.14283\/jpad.2022.81","article-title":"Socioeconomic status and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 39 prospective studies","volume":"10","author":"Wang AY","year":"2023","unstructured":"Wang AY, Hu HY, Ou YN, Wang ZT, Ma YH, Tan L, Yu JT. Socioeconomic status and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 39 prospective studies. J Prev Alzheimers Dis. 2023, 10:83-94. 10.14283\/jpad.2022.81","journal-title":"J Prev Alzheimers Dis"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12694","article-title":"Global estimates on the number of persons across the Alzheimer's disease continuum","volume":"19","author":"Gustavsson A","year":"2023","unstructured":"Gustavsson A, Norton N, Fast T, et al.. Global estimates on the number of persons across the Alzheimer's disease continuum. Alzheimers Dement. 2023, 19:658-70. 10.1002\/alz.12694","journal-title":"Alzheimers Dement"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2022.08.001","article-title":"Brief cognitive tests as a decision-making tool in primary care. A population and validation study","volume":"39","author":"Tainta M","year":"2024","unstructured":"Tainta M, Iriondo A, Ecay-Torres M, et al.. Brief cognitive tests as a decision-making tool in primary care. A population and validation study. Neurologia (Engl Ed). 2024, 39:781-91. 10.1016\/j.nrleng.2022.08.001","journal-title":"Neurologia (Engl Ed)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01595-5","article-title":"Development and assessment of algorithms for predicting brain amyloid positivity in a population without dementia","volume":"16","author":"Le Scouarnec L","year":"2024","unstructured":"Le Scouarnec L, Bouteloup V, van der Veere PJ, et al.. Development and assessment of algorithms for predicting brain amyloid positivity in a population without dementia. Alzheimers Res Ther. 2024, 16:219. 10.1186\/s13195-024-01595-5","journal-title":"Alzheimers Res Ther"},{"key":"ref57","unstructured":"Monthly deaths by cause (chapters) by sex. (2023). Accessed. April 14, 2024: https:\/\/www.ine.es\/jaxi\/Tabla.htm?tpx=73575."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.regg.2017.07.006","article-title":"Map of Alzheimer's disease and other dementias in Spain. MapEA Project (Article in Spanish)","volume":"53","author":"Mart\u00ednez-Lage P","year":"2018","unstructured":"Mart\u00ednez-Lage P, Mart\u00edn-Carrasco M, Arrieta E, Rodrigo J, Formiga F. Map of Alzheimer's disease and other dementias in Spain. MapEA Project (Article in Spanish). Rev Esp Geriatr Gerontol. 2018, 53:26-37. 10.1016\/j.regg.2017.07.006","journal-title":"Rev Esp Geriatr Gerontol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010783.pub2","article-title":"Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)","volume":"2015","author":"Arevalo-Rodriguez I","year":"2015","unstructured":"Arevalo-Rodriguez I, Smailagic N, Roqu\u00e9 I Figuls M, et al.. Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2015, 2015:CD010783. 10.1002\/14651858.CD010783.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-00977-5","article-title":"Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease","volume":"20","author":"Schindler SE","year":"2024","unstructured":"Schindler SE, Galasko D, Pereira AC, et al.. Acceptable performance of blood biomarker tests of amyloid pathology - recommendations from the Global CEO Initiative on Alzheimer's Disease. Nat Rev Neurol. 2024, 20:426-39. 10.1038\/s41582-024-00977-5","journal-title":"Nat Rev Neurol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2024.2415985","article-title":"Novel techniques for early diagnosis and monitoring of Alzheimer's disease","volume":"25","author":"Parul","year":"2025","unstructured":"Parul, Singh A, Shukla S. Novel techniques for early diagnosis and monitoring of Alzheimer's disease. Expert Rev Neurother. 2025, 25:29-42. 10.1080\/14737175.2024.2415985","journal-title":"Expert Rev Neurother"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12756","article-title":"The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease","volume":"18","author":"Hansson O","year":"2022","unstructured":"Hansson O, Edelmayer RM, Boxer AL, et al.. The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease. Alzheimers Dement. 2022, 18:2669-86. 10.1002\/alz.12756","journal-title":"Alzheimers Dement"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-00989-1","article-title":"Alzheimer disease blood biomarkers: considerations for population-level use","volume":"20","author":"Mielke MM","year":"2024","unstructured":"Mielke MM, Fowler NR. Alzheimer disease blood biomarkers: considerations for population-level use. Nat Rev Neurol. 2024, 20:495-504. 10.1038\/s41582-024-00989-1","journal-title":"Nat Rev Neurol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1002\/alz.14199","article-title":"Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: navigating clinician-patient engagement","volume":"20","author":"Rentz DM","year":"2024","unstructured":"Rentz DM, Aisen PS, Atri A, et al.. Benefits and risks of FDA-approved amyloid-targeting antibodies for treatment of early Alzheimer's disease: navigating clinician-patient engagement. Alzheimers Dement. 2024, 20:8162-71. 10.1002\/alz.14199","journal-title":"Alzheimers Dement"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00472-x","article-title":"Understanding barriers along the patient journey in Alzheimer's disease using social media data","volume":"12","author":"Tahami Monfared AA","year":"2023","unstructured":"Tahami Monfared AA, Stern Y, Doogan S, Irizarry M, Zhang Q. Understanding barriers along the patient journey in Alzheimer's disease using social media data. Neurol Ther. 2023, 12:899-918. 10.1007\/s40120-023-00472-x","journal-title":"Neurol Ther"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3390\/nursrep14020071","article-title":"Interventions effective in decreasing burden in caregivers of persons with dementia: a meta-analysis","volume":"14","author":"Rodr\u00edguez-Alc\u00e1zar FJ","year":"2024","unstructured":"Rodr\u00edguez-Alc\u00e1zar FJ, Ju\u00e1rez-Vela R, S\u00e1nchez-Gonz\u00e1lez JL, Mart\u00edn-Vallejo J. Interventions effective in decreasing burden in caregivers of persons with dementia: a meta-analysis. Nurs Rep. 2024, 14:931-45. 10.3390\/nursrep14020071","journal-title":"Nurs Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.14283\/jarlife.2022.7","article-title":"Modelling the pan-European economic burden of Alzheimer's disease","volume":"11","author":"Martins R","year":"2022","unstructured":"Martins R, Urbich M, Br\u00e4nnvall K, Gianinazzi M, Ching JE, Khoury CP, El-Hayek YH. Modelling the pan-European economic burden of Alzheimer's disease. JAR Life. 2022, 11:38-46. 10.14283\/jarlife.2022.7","journal-title":"JAR Life"},{"key":"ref68","unstructured":"Assets by sex and age group. Absolute values \u200b\u200band percentages relative to the total for each sex. (2025). Accessed. December 11, 2025: https:\/\/www.ine.es\/jaxiT3\/Tabla.htm?t=65080&L=0."},{"key":"ref69","unstructured":"Law 39\/2006, of December 14, on the promotion of personal autonomy and care for people in situations of dependency. (2025). Accessed. March 25, 2025: https:\/\/www.boe.es\/buscar\/doc.php?id=BOE-A-2006-21990."},{"key":"ref70","unstructured":"The World Wide FINGERS. (2025). Accessed. March 25, 2025: https:\/\/www.alz.org\/wwfingers\/overview.asp."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/436521-a-systematic-literature-review-of-the-epidemiological-diagnostic-workup-humanistic-and-economic-burden-of-alzheimers-disease-in-spain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:58:37Z","timestamp":1768467517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/436521-a-systematic-literature-review-of-the-epidemiological-diagnostic-workup-humanistic-and-economic-burden-of-alzheimers-disease-in-spain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":70,"URL":"https:\/\/doi.org\/10.7759\/cureus.101581","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,15]]}}}